Lind T, Andersson T, Skånberg I, Olbe L
Department of Surgery II, Sahlgrenska Sjukhuset, Göteborg, Sweden.
Clin Pharmacol Ther. 1987 Nov;42(5):504-8. doi: 10.1038/clpt.1987.188.
We have studied the biliary excretion of [14C] omeprazole in humans. The study was performed in eight healthy subjects and the technique used was based on multiple marker dilution principles with double-lumen tubes placed in both the stomach and intestine. The results obtained show a 16% biliary excretion of [14C] omeprazole. These data suggest a minimal "spillover" of omeprazole from the gastric mucosa into the gastric lumen in humans. The results also agree with previous data of the fecal recovery of radiolabeled omeprazole that suggest that the fecal excretion of intravenous omeprazole in humans is entirely accounted for by biliary excretion.
我们研究了[14C]奥美拉唑在人体中的胆汁排泄情况。该研究在8名健康受试者中进行,所采用的技术基于多标记物稀释原理,使用双腔管分别置于胃和肠道。获得的结果显示,[14C]奥美拉唑的胆汁排泄率为16%。这些数据表明,在人体中,奥美拉唑从胃黏膜向胃腔的“溢出”极少。这些结果也与先前关于放射性标记奥美拉唑粪便回收率的数据一致,这些数据表明,人体中静脉注射奥美拉唑的粪便排泄完全由胆汁排泄所致。